252 related articles for article (PubMed ID: 21519841)
41. Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16).
Sim SH; Park IH; Jung KH; Kim SB; Ahn JH; Lee KH; Im SA; Im YH; Park YH; Sohn J; Kim YJ; Lee S; Kim HJ; Chae YS; Park KH; Nam BH; Lee KS; Ro J
Br J Cancer; 2019 Dec; 121(12):985-990. PubMed ID: 31690831
[TBL] [Abstract][Full Text] [Related]
42. Clinical pharmacokinetics of vinorelbine.
Levêque D; Jehl F
Clin Pharmacokinet; 1996 Sep; 31(3):184-97. PubMed ID: 8877249
[TBL] [Abstract][Full Text] [Related]
43. Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients.
Sabot C; Marquet P; Debord J; Carpentier N; Merle L; Lachâtre G
Eur J Clin Pharmacol; 1998 Apr; 54(2):171-5. PubMed ID: 9626924
[TBL] [Abstract][Full Text] [Related]
44. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration.
Haug KG; Weber B; Hochhaus G; Butterweck V
Eur J Pharm Sci; 2012 Jan; 45(1-2):79-89. PubMed ID: 22085634
[TBL] [Abstract][Full Text] [Related]
45. Population pharmacokinetics of intravenous bolus etomidate in children over 6 months of age.
Lin L; Zhang JW; Huang Y; Bai J; Cai MH; Zhang MZ
Paediatr Anaesth; 2012 Apr; 22(4):318-26. PubMed ID: 21917057
[TBL] [Abstract][Full Text] [Related]
46. Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases.
Hong Y; Shaw PJ; Nath CE; Yadav SP; Stephen KR; Earl JW; McLachlan AJ
Antimicrob Agents Chemother; 2006 Mar; 50(3):935-42. PubMed ID: 16495254
[TBL] [Abstract][Full Text] [Related]
47. Population pharmacokinetics of total and unbound plasma cisplatin in adult patients.
Urien S; Lokiec F
Br J Clin Pharmacol; 2004 Jun; 57(6):756-63. PubMed ID: 15151521
[TBL] [Abstract][Full Text] [Related]
48. Population pharmacokinetics of adefovir dipivoxil tablets in healthy Chinese volunteers.
Huang J; Zhang Y; Huang X; Li L; Li Y; Wang K; Yang J; He Y; Lv Y; Zheng Q
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):8-14. PubMed ID: 24219967
[TBL] [Abstract][Full Text] [Related]
49. Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates.
Fanta S; Jönsson S; Backman JT; Karlsson MO; Hoppu K
Br J Clin Pharmacol; 2007 Dec; 64(6):772-84. PubMed ID: 17662086
[TBL] [Abstract][Full Text] [Related]
50. The absolute bioavailability of oral vinorelbine in patients with solid tumors.
Lush RM; McCune JS; Tetteh L; Thompson JA; Mahany JJ; Garland L; Suttle AB; Sullivan DM
Cancer Chemother Pharmacol; 2005 Dec; 56(6):578-84. PubMed ID: 16001165
[TBL] [Abstract][Full Text] [Related]
51. The pharmacokinetics of epirubicin and docetaxel in combination in rats.
Sandström M; Simonsen LE; Freijs A; Karlsson MO
Cancer Chemother Pharmacol; 1999; 44(6):469-74. PubMed ID: 10550567
[TBL] [Abstract][Full Text] [Related]
52. Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer.
Ouellet D; Periclou AP; Johnson RD; Woodworth JR; Lalonde RL
Cancer Chemother Pharmacol; 2000; 46(3):227-34. PubMed ID: 11021740
[TBL] [Abstract][Full Text] [Related]
53. Population pharmacokinetic analysis of patritumab, a HER3 inhibitor, in subjects with advanced non-small cell lung cancer (NSCLC) or solid tumors.
Yoshiba S; Jansen M; Matsushima N; Chen S; Mendell J
Cancer Chemother Pharmacol; 2016 May; 77(5):987-96. PubMed ID: 27017616
[TBL] [Abstract][Full Text] [Related]
54. A limited-sampling strategy to estimate individual pharmacokinetic parameters of vinorelbine in elderly patients with advanced metastatic cancer.
Gauvin A; Pinguet F; Culine S; Astre C; Gomeni R; Bressolle F
Anticancer Drugs; 2002 Jun; 13(5):473-80. PubMed ID: 12045458
[TBL] [Abstract][Full Text] [Related]
55. Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors.
Thai HT; Veyrat-Follet C; Mentré F; Comets E
Cancer Chemother Pharmacol; 2013 Jul; 72(1):167-80. PubMed ID: 23673444
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics of vinorelbine in patients with liver metastases.
Robieux I; Sorio R; Borsatti E; Cannizzaro R; Vitali V; Aita P; Freschi A; Galligioni E; Monfardini S
Clin Pharmacol Ther; 1996 Jan; 59(1):32-40. PubMed ID: 8549031
[TBL] [Abstract][Full Text] [Related]
57. A Systematic Review and Meta-analysis of the Combination of Vinorelbine and Lapatinib in Patients With Her2-positive Metastatic Breast Cancer.
Stravodimou A; Voutsadakis IA
Anticancer Res; 2019 Jul; 39(7):3295-3301. PubMed ID: 31262849
[TBL] [Abstract][Full Text] [Related]
58. The pharmacokinetics of methadone in adolescents undergoing posterior spinal fusion.
Stemland CJ; Witte J; Colquhoun DA; Durieux ME; Langman LJ; Balireddy R; Thammishetti S; Abel MF; Anderson BJ
Paediatr Anaesth; 2013 Jan; 23(1):51-7. PubMed ID: 22978825
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial data.
Molina JR; Kaufmann SH; Reid JM; Rubin SD; Gálvez-Peralta M; Friedman R; Flatten KS; Koch KM; Gilmer TM; Mullin RJ; Jewell RC; Felten SJ; Mandrekar S; Adjei AA; Erlichman C
Clin Cancer Res; 2008 Dec; 14(23):7900-8. PubMed ID: 19047120
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer.
Sorio R; Robieux I; Galligioni E; Freschi A; Colussi AM; Crivellari D; Saracchini S; Monfardini S
Eur J Cancer; 1997 Feb; 33(2):301-3. PubMed ID: 9135505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
